SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001399529-19-000028
Filing Date
2019-08-08
Accepted
2019-08-08 16:25:40
Documents
57
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q drna-20190630x10q.htm 10-Q 1241594
2 EXHIBIT 31.1 drnaex311.htm EX-31.1 7963
3 EXHIBIT 31.2 drnaex312.htm EX-31.2 7943
4 EXHIBIT 32.1 drnaex321.htm EX-32.1 7303
11 dicernapipelinechartjul30201.jpg GRAPHIC 154617
  Complete submission text file 0001399529-19-000028.txt   4599774

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT drna-20190630.xml EX-101.INS 706456
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT drna-20190630.xsd EX-101.SCH 39119
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT drna-20190630_cal.xml EX-101.CAL 58077
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT drna-20190630_def.xml EX-101.DEF 137558
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT drna-20190630_lab.xml EX-101.LAB 444136
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT drna-20190630_pre.xml EX-101.PRE 254717
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 191009951
SIC: 2834 Pharmaceutical Preparations